Literature DB >> 22064462

Immunotherapy: a first for first-line therapy in NSCLC.

Rebecca Kirk.   

Abstract

Entities:  

Year:  2011        PMID： 22064462     DOI： 10.1038/nrclinonc.2011.172

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

Authors:  Elisabeth Quoix; Rodryg Ramlau; Virginie Westeel; Zsolt Papai; Anne Madroszyk; Alain Riviere; Piotr Koralewski; Jean-Luc Breton; Erich Stoelben; Denis Braun; Didier Debieuvre; Hervé Lena; Marc Buyse; Marie-Pierre Chenard; Bruce Acres; Gisèle Lacoste; Bérangère Bastien; Annette Tavernaro; Nadine Bizouarne; Jean-Yves Bonnefoy; Jean-Marc Limacher
Journal:  Lancet Oncol       Date:  2011-10-21       Impact factor: 41.316
  1 in total
  3 in total

1.  TAG-RNAi overcomes off-target effects in cancer models.

Authors:  Julien Champagne; Laetitia K Linares; Benjamin Maurel; Alexandre Zampieri; Maeva Moreno; Ivanna Fuentes; Emeric Dubois; Dany Severac; Adrien Decorsière; Frédéric Bienvenu
Journal:  Oncogene       Date:  2019-09-26       Impact factor: 9.867

2.  New insights and clinical advancements in cellular oncology.

Authors:  Ad Geurts van Kessel
Journal:  Cell Oncol (Dordr)       Date:  2012-06       Impact factor: 6.730

3.  Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer.

Authors:  Lisanne Heim; Katerina Kachler; Raphaela Siegmund; Denis I Trufa; Susanne Mittler; Carol-Immanuel Geppert; Juliane Friedrich; Ralf J Rieker; Horia Sirbu; Susetta Finotto
Journal:  Br J Cancer       Date:  2019-04-08       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.